NuCana (NCNA) Change in Working Capital (2017 - 2021)
NuCana (NCNA) reported Change in Working Capital of $31.0 million for Q4 2021, up 35.19% on a YoY basis from $22.9 million in Q4 2020, and up 331.18% sequentially from -$13.4 million in Q3 2021.
NuCana (NCNA) Change in Working Capital (2017 - 2021) Analysis & Trends
NuCana (NCNA) has 5 years of Change in Working Capital data on file, last reported at $31.0 million in Q4 2021.
- For the quarter ending Q4 2021, Change in Working Capital rose 35.19% year-over-year to $31.0 million; the trailing twelve-month figure through Dec 2021 stood at -$6.5 million (down 301.46% YoY), and the FY2025 full-year result was $4.8 million, up 73.5% from the prior year.
- Change in Working Capital rose to $31.0 million in Q4 2021, from -$13.4 million in the prior quarter.
- In the past five years, Change in Working Capital ranged from a high of $31.0 million in Q4 2021 to a low of -$13.4 million in Q3 2021.
- A 5-year average of -$16875.1 and a median of -$6.5 million in 2019 frame the typical range for Change in Working Capital.
- Across the five-year window, Change in Working Capital jumped 116.04% in 2018 and slumped 63.45% in 2021, its largest moves.
- Tracing NCNA's Change in Working Capital over 5 years: stood at $10.5 million in 2017, then jumped by 116.04% to $22.6 million in 2018, then retreated by 20.3% to $18.0 million in 2019, then advanced by 27.36% to $22.9 million in 2020, then surged by 35.19% to $31.0 million in 2021.
- Business Quant data shows NCNA's Change in Working Capital at $31.0 million in Q4 2021, -$13.4 million in Q3 2021, and -$12.0 million in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 31.00 Mn |
| Dec 31, 2021 | 31.00 Mn |
| Sep 30, 2021 | -13.41 Mn |
| Sep 30, 2021 | -13.41 Mn |
| Jun 30, 2021 | -11.97 Mn |
| Jun 30, 2021 | -11.97 Mn |
| Mar 31, 2021 | -12.13 Mn |
| Mar 31, 2021 | -12.13 Mn |
| Dec 31, 2020 | 22.93 Mn |
| Dec 31, 2020 | 22.93 Mn |
| Sep 30, 2020 | -8.21 Mn |
| Sep 30, 2020 | -8.21 Mn |
| Jun 30, 2020 | -8.00 Mn |
| Jun 30, 2020 | -8.00 Mn |
| Mar 31, 2020 | -8.35 Mn |
| Mar 31, 2020 | -8.35 Mn |
| Dec 31, 2019 | 18.01 Mn |
| Dec 31, 2019 | 18.01 Mn |
| Sep 30, 2019 | -6.26 Mn |
| Sep 30, 2019 | -6.26 Mn |